Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 21, 2026; 32(47): 124712
Published online Dec 21, 2026. doi: 10.3748/wjg.124712
Published online Dec 21, 2026. doi: 10.3748/wjg.124712
Table 3 Experimental studies and mechanisms of action of Astragalus and its active components in the chronic atrophic gastritis treatment
| Research contents | Action targets | Outcomes | Ref. |
| Astragalus membranaceus | H. pylori vacuolating cytotoxin A | Inhibition of H. pylori activity | Wang et al[58] |
| Inflammatory factors | Suppression of pro-inflammatory cytokines and immunomodulation | Liu et al[60] | |
| Th1/Th2 and Treg/Th17 immune axes | Enhancing immune tolerance | Chang et al[63] | |
| PI3K/Akt, Wnt/β-catenin, and Janus kinase-signal transducer and activator of transcription 3 pathways | Protecting the gastric mucosa | Liu et al[66]; Yan and Zhang[67] | |
| Acetobacter and Escherichia coli | Alleviating gut microbial metabolic disorders | Liu[71]; Liu et al[72] | |
| Astragaloside IV | H. pylori urease and related genes (ureA, ureB) | Attenuating the colonization ability of H. pylori | Wang et al[59] |
| CXCL5-CXCR2 axis and the NF-κB pathway | Anti-inflammatory effects and inhibition of inflammation-to-cancer transformation | Pei et al[64]; Tian et al[65] | |
| Thrombin/PAR-1, p53, and MAPK signaling pathways | Increasing gastric acid secretion and protecting the gastric mucosa | Shen et al[68]; Duan et al[69] | |
| Bifidobacterium and the Wnt3a/β-catenin signaling pathway | Regulation of serum metabolite levels and anti-tumor effects | Wen et al[73] | |
| Reactive oxygen species, serum nitric oxide, and inducible nitric oxide synthase | Antioxidant and anticancer effects and improvement of clinical efficacy in CAG | Xia et al[75]; Li et al[76] | |
| Astragalus polysaccharides | NF-κB p65/MAPK signaling pathway | Enhancement of immunomodulatory effects | Feng et al[62] |
| Epidermal growth factor receptor downstream effector proteins cyclooxygenase-2 and metalloproteinases-2 | Protection of the gastric mucosa | Zhu et al[70] | |
| Total astragalosides | Immune factors | Enhancement of immunomodulatory capacity | Zhang et al[61] |
- Citation: Tong YL, Bian QY, Zheng HX, Xiao JD. Clinical efficacy and mechanisms of Astragalus membranaceus, active components, and herbal formulas for chronic atrophic gastritis. World J Gastroenterol 2026; 32(47): 124712
- URL: https://www.wjgnet.com/1007-9327/full/v32/i47/124712.htm
- DOI: https://dx.doi.org/10.3748/wjg.124712